Clopidogrel effectively suppresses endothelial microparticle generation induced by indoxyl sulfate via inhibition of the p38 mitogen-activated protein kinase pathway

Blood Purification

Volumn 32, Issue 3, 2011, Pages 186-194

  Ryu, Jung Hwa ^a   Kim, Seung Jung ^a,b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Mokdong Hospital   (South Korea)

Author keywords

Clopidogrel; Endothelial microparticle; Human umbilical vein endothelial cell; Indoxyl sulfate; p38 mitogen activated protein kinase

Indexed keywords

CD31 ANTIGEN; CLOPIDOGREL; INDICAN; LOSARTAN; MESOGLYCAN; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; INDICAN; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; UMBILICAL VEINS;

EID: 79960883292     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000326297     Document Type: Article

References (41)

1. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 2006; 17: 1112-1127.
2. Rekhter M, Nicholls S, Ferguson M, Gordon D: Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 1993; 13: 609-617. (Pubitemid 23107135)
3. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-2334. (Pubitemid 32467627)
4. Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Part I. Circulation 2003; 108: 1527-1532. (Pubitemid 37176462)
5. Roy-Chaudhury P, Kelly BS, Zhang J, Narayana A, Desai P, Melham M, Duncan H, Heffelfinger SC: Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 2003; 21: 99-110. (Pubitemid 36173356)
6. Diamant M, Tushuizen ME, Sturk A, Nieuwland R: Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392-401. (Pubitemid 38859560)
7. Freyssinet JM: Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003; 1: 1655-1662.
8. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381-3388. (Pubitemid 46179341)
9. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, Sturk A, Dignat-George F, Sabatier F, Camoin-Jau L, Sampol J, Hugel B, Zobairi F, Freyssinet JM, Nomura S, Shet AS, Key NS, Hebbel RP: Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-1851. (Pubitemid 40197488)
10. Morel O, Morel N, Hugel B, Jesel L, Vinzio S, Goichot B, Bakouboula B, Grunebaum L, Freyssinet JM, Toti F: The significance of circulating microparticles in physiology, inflammatory and thrombotic diseases (in French). Rev Med Interne 2005; 26: 791-801. (Pubitemid 41463468)
11. Zwaal RF, Comfurius P, Bevers EM: Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1992; 1180: 1-8.
12. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A: Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353. (Pubitemid 29051259)
13. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, de Marchena E, Ahn YS: High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962-970. (Pubitemid 36688245)
14. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H: Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622-1630. (Pubitemid 40704497)
15. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102. (Pubitemid 29534349)
16. McFarlane SI, Muniyappa R, Francisco R, Sowers JR: Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab 2002; 87: 1451-1458. (Pubitemid 34615220)
17. Fujita M, Okuda H, Tsukamoto O, Asano Y, Hirata YL, Kim J, Miyatsuka T, Takashima S, Minamino T, Tomoike H, Kitakaze M: Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26:e138-e142. (Pubitemid 44465705)
18. Savi P, Bernat A, Dumas A, Ait-Chek L, Herbert JM: Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells. Thromb Res 1994; 73: 117-124. (Pubitemid 24057986)
19. Tanganelli P, Bianciardi G, Carducci A, Palummo N, Simoes C, Tarabochia B, Weber G, Verzuri MS, Auteri A: Updating on in-vivo and in-vitro effects of heparin and other glycosaminoglycans (mesoglycan) on arterial endothelium: a morphometrical study. Int J Tissue React 1992; 14: 149-153.
20. Shimizu H, Hirose Y, Nishijima F, Tsubakihara Y, Miyazaki H: Ros and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol 2009; 297:C389-C396.
21. Yamamoto H, Tsuruoka S, Ioka T, Ando H, Ito C, Akimoto T, Fujimura A, Asano Y, Kusano E: Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 2006; 69: 1780-1785. (Pubitemid 43739205)
22. Kim SJ, Masaki T, Leypoldt JK, Kamerath CD, Mohammad SF, Cheung AK: Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs. J Lab Clin Med 2004; 144: 156-162. (Pubitemid 39349037)
23. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622. (Pubitemid 28248586)
24. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295: 1556-1565.
25. Worthley SG, Helft G, Corti R, Worthley MI, Chew DP, Fayad ZA, Zaman AG, Fallon JT, Fuster V, Badimon JJ: Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiol Haemost Thromb 2007; 36: 9-17. (Pubitemid 351373318)
26. Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM: Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999; 100: 1223-1229. (Pubitemid 29426599)
27. Brasier AR, Recinos A 3rd, Eledrisi MS: Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002; 22: 1257-1266. (Pubitemid 34875734)
28. Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F, Pedrinelli R: Antiinflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 2008; 198: 22-28. (Pubitemid 351406364)
29. Dunzendorfer S, Reinisch CM, Kaneider NC, Pechlaner C, Wiedermann CJ: Inhibition of plasma-dependent monocyte chemokinesis and cytokine-triggered endothelial activation for neutrophil transmigration by administration of clopidogrel in man. Acta Med Austriaca 2002; 29: 100-106. (Pubitemid 34994760)
30. Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F: Treatment of intermittent claudication with mesoglycan-a placebo-controlled, double-blind study. Thromb Haemost 2001; 86: 1181-1187. (Pubitemid 33064565)
31. Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T: Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb Hemost 2004; 10: 133-141. (Pubitemid 38490081)
32. Tramontano AF, O'Leary J, Black AD, Muniyappa R, Cutaia MV, El-Sherif N: Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Commun 2004; 320: 34-38. (Pubitemid 38781781)
33. Shen J, DiCorleto PE: ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 2008; 102: 448-456. (Pubitemid 351651109)
34. Curtis AM, Wilkinson PF, Gui M, Gales TL, Hu E, Edelberg JM: P38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. J Thromb Haemost 2009; 7: 701-709.
35. Cerini C, Dou L, Anfosso F, Sabatier F, Moal V, Glorieux G, De Smet R, Vanholder R, Dignat-George F, Sampol J, Berland Y, Brunet P: P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004; 92: 140-150. (Pubitemid 39010877)
36. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451. (Pubitemid 38130638)
37. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P: The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 2007; 5: 1302-1308. (Pubitemid 46902134)
38. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573.
39. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z: Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649-2652. (Pubitemid 33108128)
40. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS: Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004; 286:H1910-H1915. (Pubitemid 38525481)
41. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277-287. (Pubitemid 37272022)